Occam Recruits CBO for Parisian Generative AI Drug Discovery Platform Company, Iktos
In January 2024, Occam recruited Avirup Bose, Ph.D., as Chief Business Officer of Iktos, a Paris-based biotech leveraging Artificial Intelligence for new drug design and an M Ventures investment.
Avirup previously served as VP of Business Development at Chinook Therapeutics (NASDAQ: KDNY), where he was instrumental in engineering many important strategic collaboration agreements. Chinook was acquired by Novartis in 2023. Prior to Chinook, Bose spent 17 years at Novartis, where he held positions of increasing responsibility in research, portfolio management, licensing, and business development.
Occam is a globally recognized leader in recruiting AI innovators for the life sciences. Check out Occam President John Holdonak's recent blog on the AI-ML Revolution in Drug R&D.
Occam Global is an international life science executive search and leadership advisory firm dedicated to building management teams for innovative companies in the biotech, techbio, life sciences, and venture capital sectors. Our firm’s unique strength lies in our seamless access to elite talent, proven expertise in aligning exceptional business and scientific leaders with optimal opportunities, and a steadfast dedication to creating meaningful industry impact, guided by elevated ethics and enlightened aggression. Trusted by entrepreneurs, investors, and corporations worldwide, Occam Global is recognized as the premier partner for executive search and recruitment in the life sciences. Our success is rooted in establishing trust, cultivating and valuing relationships, and committing to serve as forthright and good-humored partners in realizing extraordinary ambitions.